Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19

View/ Open
Issue date
2021Author
Buxeda, Anna
Arias Cabrales, Carlos
Pérez Sáez, María José
Cacho, Judit
Cabello Pelegrin, Sheila
Melilli, Edoardo
Aladrén, María José
Galeano, Cristina
Lorenzo, Inmaculada
Mazuecos, Auxiliadora
Saura, Isabel María
Franco, Antonio
Ruiz Fuentes, María del Carmen
Sánchez Cámara, Luis Alberto
Siverio, Orlando
Martín Conde, María Luisa
González García, Elena
López, Verónica
Martin Moreno, Paloma Leticia
Moina, Iñigo
Moral Berrio, Esperanza
Moreso, Francesc
Portolés, José María
Santana Estupiñán, Raquel
Zárraga, Sofía
Canal, Cristina
Sánchez Álvarez, Emilio
Pascual, Julio
Crespo, Marta
Suggested citation
Buxeda, Anna;
Arias Cabrales, Carlos;
Pérez Sáez, María José;
Cacho, Judit;
Cabello Pelegrin, Sheila;
Melilli, Edoardo;
...
Crespo, Marta.
(2021)
.
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19.
Kidney International Reports, 2021, vol. 6, núm. 9, p. 2305-2315.
https://doi.org/10.1016/j.ekir.2021.06.023.
Metadata
Show full item recordAbstract
Introduction:Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time torecovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acutekidney injury have been reported. Scant data are available on the use and safety of remdesivir in kidneytransplant recipients.Methods:We present a multicenter cohort study of 51 kidney transplant recipients with COVID-19 treatedwith remdesivir. Outcomes and safety were assessed.Results:Mean age at diagnosis was 60 years, with a median time since kidney transplant of 4.5years. Mean time since admission to remdesivir was 2 days. Twenty-eight patients (54.9%) requiredmechanical ventilation (19 noninvasive). Mortality was 18.9% and markedly higher if aged$65 years(45% vs. 3.2% in younger patients). Acute kidneyinjury was present in 27.7% of patients, but wasdiagnosed in 50% before treatment. No patients required remdesivir discontinuation because ofadverse events. We did notfind significant hepatoxicity or systemicsymptoms resulting from thedrug.
Conclusion:In our cohort of kidney transplant recipients, remdesivir was well tolerated and safe in renaland hepatic toxicity, but randomized trials are needed to assess its efficacy.
Is part of
Kidney International Reports, 2021, vol. 6, núm. 9, p. 2305-2315European research projects
Collections
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by-nc-nd (c) International Society of Nephrology, 2021
Related items
Showing items related by title, author, creator and subject.
-
Documento internacional de consenso sobre apnea obstructiva del sueño
Mediano, Olga; González Mangado, Nicolas; Montserrat, Josep Maria; Alonso Álvarez, María Luz; Almendros, Isaac; Alonso Fernández, Alberto; Barbé Illa, Ferran; Borsini, Eduardo; Caballero-Eraso, Candela; Cano-Pumarega, Irene; Carlos Villafranca, Felix Antonio De; Carmona Bernal, Carmen; Carrillo Alduenda, Jose Luis; Chiner, Eusebi; Cordero Guevara, Jose Aurelio; de Manuel, Luis; Durán-Cantolla, Joaquín; Farré, Ramon; Franceschini, Carlos; Gaig, Carles; García Ramos, Pedro; García-Río, Francisco; Garmendia, Onintza; Gómez García, Teresa; González Pondal, Silvia; Hoyo Rodrigo, Blanca M.; Lecube Torelló, Albert; Madrid, Juan Antonio; Maniegas Lozano, Lourdes; Martínez Carrasco, José Luis; Masa, Juan F.; Masdeu Margalef, María José; Mayos Pérez, Mercè; Mirabet Lis, Enrique; Monasterio, Carmen; Navarro Soriano, Nieves; Olea de la Fuente, Erika; Plaza, Guillermo; Puertas Cuesta, Francisco Javier; Rabec, Claudio; Resano, Pilar; Rigau, David; Roncero, Alejandra; Ruiz, Concepción; Salord, Neus; Saltijeral, Adriana; Sampol, Gabriel; Sánchez Quiroga, María Ángeles; Sans Capdevila, Oscar; Teixeira, Carlos; Tinahones, Francisco José; Togeiro, Sonia María; Troncoso Acevedo, Maria Fernanda; Vargas Ramírez, Leslie Katherine; Winck, Joao; Zabala Urionaguena, Nerea; Egea, Carlos (Elsevier, 2021)Themainaimofthis international consensusdocument onobstructive sleepapnea is toprovide guidelines based on a critical analysis of the latest literature to help health professionals make the best decisions in the care of ... -
New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”
de Hollanda, Ana; Lecube Torelló, Albert; Rubio, Miguel Ángel; Sánchez Peña, Enric; Vilarrasa, Núria; Gregorio Oliva, José; Fernández-Soto, María Luisa; Salas-Salvadó, Jordi; Ballesteros-Pomar, María D.; Ciudin, Andreea; Torres, Ferran; Vidal, Concepción; Morales, María José; Valdés, Sergio; Pellitero, Silvia; Miñambres, Inka; Masmiquel, Lluís; Goday, Albert; Suarez, Lorena; Flores, Liliam; Bueno Díez, Marta; Caixàs, Assumpta; Bretón, Irene; Cámara, Rosa; Olbeyra, Romina; Penso, Rona; de la Cruz, María José; Simó-Servat, Andreu; Pereyra-García, Francisca María; López-Mezquita, Elena Teresa; Gils, Anna; Fidilio, Enzamaria; Bandrés, Orosia; Martínez, Ángel; Abuín, Jose; Marques-Pamies, Montserrat; Tuneu, Laura; Arteaga, Magdalena; Castañer, Olga; Goñi, Fernando; Arrizabalaga, Cristina; Botana, Manuel Antonio; Calañas, Alfonso (MDPI, 2020)Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after ... -
Daptomycin plus fosfomycin versus daptomycin alone for methicillin-resistant staphylococcus aureus bacteremia and endocarditis: a randomized clinical trial
Pujol, Miquel; Miró, José María; Shaw, Evelyn; Aguado, Jose María; San Juan, Rafael; Puig Asensio, Mireia; Pigrau, Carles; Calbo Sebastian, Esther; Montejo, Miguel; Rodríguez Álvarez, Regino; García Pais, María Jose; Pintado, Vicente; Escudero Sánchez, Rosa; López Contreras, Joaquín; Morata, Laura; Montero, Milagros; Andrés, Marta; Pasquau, Juan; Arenas, María del Mar; Padilla, Belén; Murillas, Javier; Jover, Alfredo; López Cortes, Luis Eduardo; García Pardo, Graciano; Gasch, Oriol; Videla, Sebastian; Hereu, Pilar; Tebé, Cristian; Pallarès, Natalia; Sanllorente, Mireia; Domínguez, María Ángeles; Càmara, Jordi; Ferrer, Anna; Padullés, Ariadna; Cuervo, Guillermo; Carratalà, Jordi (Oxford University Press; Infectious Diseases Society of America, 2021)Background. We aimed to determine whether daptomycin plus fosfomycin provides higher treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis.Methods. A ...